Additional file 1: Table S1. Peptides with a statistically significant (p < 0.05) urinary abundance (m/z area) according to the tumour mass (cm). Up/down refer to the over/under representation of the peptide in ccRCC patients compared to control subjects
Additional file 6. Table S5. List of exclusively upregulated, exclusively downregulated, and up- or ...
<p><b>Mw-</b>Molecular weight of apoprotein obtained from protein database.</p><p><b>Protein expecta...
Additional file 4. Table S3. Coefficient of variation (CV%) values of the sums of logarithm base two...
Additional file 3: Table S3. A) Peptides with a statistical significant (p < 0.05) urinary abundan...
Additional file 2: Table S2. A) Peptides with a statistically significant (p < 0.05) urinary abund...
Additional file 4: Table S4. Peptides with a statistically significant (p > 0.05) urinary abundanc...
Background: Several promising biomarkers have been found for RCC, but none of them has been used in ...
Background: Several promising biomarkers have been found for RCC, but none of them has been used in ...
Additional file 5: Table S5. Identification of MALDI signals varied according to tumour size, pT o...
Additional file 3. Table S2. The number of identified and quantified proteins in individual samples ...
Additional file 2: Table S2 Average Chi Square value per gene symbol for ovarian cancer versus norma...
Additional file 7: Figure S2. Performance of the urinary proteome profiling workflow in peptide leve...
The emergence of mass spectrometry (MS)-based signatures as biomarkers has generated considerable en...
Figure S4. a) Contingency table showing the frequency distribution of CCDC6 intensity IHC staining v...
<p>The relative protein expression of PNCK in ccRCC tumor (T) tissue samples was higher than that in...
Additional file 6. Table S5. List of exclusively upregulated, exclusively downregulated, and up- or ...
<p><b>Mw-</b>Molecular weight of apoprotein obtained from protein database.</p><p><b>Protein expecta...
Additional file 4. Table S3. Coefficient of variation (CV%) values of the sums of logarithm base two...
Additional file 3: Table S3. A) Peptides with a statistical significant (p < 0.05) urinary abundan...
Additional file 2: Table S2. A) Peptides with a statistically significant (p < 0.05) urinary abund...
Additional file 4: Table S4. Peptides with a statistically significant (p > 0.05) urinary abundanc...
Background: Several promising biomarkers have been found for RCC, but none of them has been used in ...
Background: Several promising biomarkers have been found for RCC, but none of them has been used in ...
Additional file 5: Table S5. Identification of MALDI signals varied according to tumour size, pT o...
Additional file 3. Table S2. The number of identified and quantified proteins in individual samples ...
Additional file 2: Table S2 Average Chi Square value per gene symbol for ovarian cancer versus norma...
Additional file 7: Figure S2. Performance of the urinary proteome profiling workflow in peptide leve...
The emergence of mass spectrometry (MS)-based signatures as biomarkers has generated considerable en...
Figure S4. a) Contingency table showing the frequency distribution of CCDC6 intensity IHC staining v...
<p>The relative protein expression of PNCK in ccRCC tumor (T) tissue samples was higher than that in...
Additional file 6. Table S5. List of exclusively upregulated, exclusively downregulated, and up- or ...
<p><b>Mw-</b>Molecular weight of apoprotein obtained from protein database.</p><p><b>Protein expecta...
Additional file 4. Table S3. Coefficient of variation (CV%) values of the sums of logarithm base two...